Načítá se...
Alopecia universalis and onychodystrophy during treatment with adalimumab
Alopecia universalis, the complete loss of body hair, during anti–tumor necrosis factor-alpha (TNF-α) biologic therapy is a rare occurrence that has infrequently been reported in the literature. In this case, a 50-year-old man with psoriatic arthritis exhibited alopecia universalis with concomitant...
Uloženo v:
| Vydáno v: | Proc (Bayl Univ Med Cent) |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7549934/ https://ncbi.nlm.nih.gov/pubmed/33100536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/08998280.2020.1771140 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|